TIFFANY TURNER: Open Payments
NPI 1629600325 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,525 in 63 payments from 8 companies in 2025. Trend: 2023 $3,562 · 2024 $3,059 · 2025 $8,525
Consulting: $3,850Food & beverage: $3,519Travel & lodging: $1,156
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 29 | $6,594 |
| ViiV Healthcare Company | 19 | $930 |
| AstraZeneca Pharmaceuticals LP | 4 | $485 |
| Lilly USA, LLC | 3 | $179 |
| ABBVIE INC. | 4 | $152 |
| EMD Serono, Inc. | 1 | $109 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| Hologic Sales and Service, LLC | 1 | $17 |
Products named: Yeztugo, TEZSPIRE, DOVATO, CABENUVA, MAVYRET, Veklury, Descovy, Epclusa.
Industry payments across PA — which companies pay providers there.
